Definitive Healthcare (NASDAQ:DH) Updates FY 2024 Earnings Guidance

by · The Cerbat Gem

Definitive Healthcare (NASDAQ:DH – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.340-0.350 for the period, compared to the consensus estimate of 0.330. The company issued revenue guidance of $250.0 million-$251.0 million, compared to the consensus revenue estimate of $249.2 million. Definitive Healthcare also updated its Q4 guidance to $0.07 EPS.

Definitive Healthcare Stock Down 1.6 %

NASDAQ:DH traded down $0.07 during trading hours on Friday, hitting $4.24. 1,200,343 shares of the company traded hands, compared to its average volume of 326,752. The firm’s 50-day simple moving average is $4.36 and its 200-day simple moving average is $4.98. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The company has a market cap of $500.02 million, a PE ratio of -1.22, a PEG ratio of 6.27 and a beta of 1.33.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DH. Robert W. Baird lowered their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Morgan Stanley decreased their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. Stifel Nicolaus dropped their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a report on Wednesday, July 31st. Finally, BTIG Research started coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target on the stock. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $5.81.

Get Our Latest Stock Report on Definitive Healthcare

About Definitive Healthcare

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Articles